+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biotech, Pharmaceuticals & Genetics Industry Almanac 2024: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies

  • PDF Icon

    Book

  • 491 Pages
  • August 2023
  • Plunkett Research Ltd
  • ID: 5411875

Key Findings:

A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights that can help shape strategy for business development, product development and investments.

Key Features:

  • Business trends analysis
  • In-depth industry overview
  • Technology trends analysis
  • Forecasts
  • Spending, investment, and consumption discussions
  • In-depth industry statistics and metrics
  • Industry employment numbers

Additional Key Features Include:

  • Industry Glossary
  • Industry Contacts list, including Professional Societies and Industry Associations
  • Profiles of industry-leading companies
  • U.S. and Global Firms
  • Publicly held, Private and Subsidiaries
  • Executive Contacts
  • Revenues
  • For Public Companies: Detailed Financial Summaries

Pages: 496

Statistical Tables Provided: 8

Companies Profiled: 350

Geographic Focus: Global

Key Questions Answered Include:

  • How is the industry evolving?
  • How is the industry being shaped by new technologies?
  • How is demand growing in emerging markets and mature economies?
  • What is the size of the market now and in the future?
  • What are the financial results of the leading companies?
  • What are the names and titles of top executives?
  • What are the top companies and what are their revenues?

This feature-rich report covers competitive intelligence, market research and business analysis - everything you need to know about the Biotech, Pharmaceuticals & Genetics Industry.

The Report Unique Analysis of the Following Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry

  1. The State of the Biotechnology Industry Today
  2. The Coronavirus’ Effect on the Biotech, Pharmaceuticals & Genetics Industry
  3. A Short History of Biotechnology
  4. Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
  5. Ethanol Production Soared, But U.S. Federal Subsidy Expired
  6. Cellulosic Ethanol Makes Slow Commercial Progress
  7. Major Drug Companies Acquire or Partner With Smaller Biotech Firms
  8. Pharmaceutical R&D Improves with Artificial Intelligence (AI)
  9. From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
  10. Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
  11. Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
  12. Vaccines & Viruses as Therapies/mRNA Shows Great Promise
  13. Massive R&D Investment Required for Development and Approval of New Drugs/Drug Prices Soar
  14. Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
  15. America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
  16. Biotech and Orphan Drugs Create New Revenues for Drug Firms
  17. Revolutionary New Drugs (Ozempic, Wegovy) Treat Obesity, Diabetes and Addiction
  18. Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
  19. Market for CBD
  20. Stem Cells and 3-D Printing - A New Era of Tissue Replacement Takes Shape
  21. Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
  22. Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
  23. Plant-Based Meat Substitutes Developed
  24. Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
  25. Immunotherapy, ADCs and CAR-T Create Exciting New Approach to Fighting Cancers
  26. Technology Discussion - Genes and DNA
  27. Technology Discussion - Proteins and Proteomics
  28. Technology Discussion - DNA Chips
  29. Technology Discussion - SNPs (“Snips”)
  30. Technology Discussion - Synthetic Biology
  31. Technology Discussion - Recombinant DNA
  32. Technology Discussion - Polymerase Chain Reaction (PCR)

The Report Provides In-Depth Tables for the FollowingBiotech, Pharmaceuticals & Genetics Industry Statistics

  1. Biotech Industry Statistics and Market Size Overview
  2. The U.S. Drug Discovery & Approval Process
  3. U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2022
  4. Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2022
  5. Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2022-2024
  6. U.S. Exports & Imports of Pharmaceutical Products: 2017-2022
  7. Prescription Drug Expenditures, U.S.: Selected Years, 2015-2031
  8. NSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2022-2024

Table of Contents


IntroductionHow to Use This Book
Chapter 1: Major Trends Affecting the Biotech, Pharmaceuticals & Genetics Industry
1) The State of the Biotechnology Industry Today
2) The Coronavirus’ Effect on the Biotech, Pharmaceuticals & Genetics Industry
3) A Short History of Biotechnology
4) Fast Track Drugs Come to Market in the U.S. with FDA Cooperation
5) Ethanol Production Soared, But U.S. Federal Subsidy Expired
6) Cellulosic Ethanol Makes Slow Commercial Progress
7) Major Drug Companies Acquire or Partner With Smaller Biotech Firms
8) Pharmaceutical R&D Improves with Artificial Intelligence (AI)
9) From Korea to India to Singapore to China, Nations Compete Fiercely in Biotech Development
10) Patients’ Genetic Profiles Plummet in Price as DNA Sequencing Technologies Advance
11) Gene Therapies Target Defective Genes/CRISPR Advances DNA Editing
12) Vaccines & Viruses as Therapies/mRNA Shows Great Promise
13) Massive R&D Investment Required for Development and Approval of New Drugs/Drug Prices Soar
14) Generic Drugs Have Biggest Market Share by Unit Volume, but not by Total Revenues
15) America Pays Higher Prices for Drugs Than Other Nations/U.S. Government Launches Drug Price Negotiation and Control Powers for Medicare
16) Biotech and Orphan Drugs Create New Revenues for Drug Firms
17) Revolutionary New Drugs (Ozempic, Wegovy) Treat Obesity, Diabetes and Addiction
18) Biosimilars (Generic Biotech Drugs) Receive FDA Guidelines for Accelerated Approval/Competition Will Be Fierce
19) Market for CBD
20) Stem Cells and 3-D Printing - A New Era of Tissue Replacement Takes Shape
21) Genetically Modified (GM) Seeds and Crops Planted in Dozens of Nations/Agribio R&D Investment Is High
22) Genetically Modified (GM) Foods Prompt Controversy, Labeling and Legislation
23) Plant-Based Meat Substitutes Developed
24) Selective Plant Breeding, Mutagenesis and Gene-Editing, Including CRISPR, as Alternatives to GM Seeds
25) Immunotherapy, ADCs and CAR-T Create Exciting New Approach to Fighting Cancers
26) Technology Discussion - Genes and DNA
27) Technology Discussion - Proteins and Proteomics
28) Technology Discussion - DNA Chips
29) Technology Discussion - SNPs (“Snips”)
30) Technology Discussion - Synthetic Biology
31) Technology Discussion - Recombinant DNA
32) Technology Discussion - Polymerase Chain Reaction (PCR)

Chapter 2: Biotech, Pharmaceuticals & Genetics Industry Statistics
  • Biotech Industry Statistics and Market Size Overview
  • The U.S. Drug Discovery & Approval Process
  • U.S. FDA New Drug (NDA) and Biologic (BLA) Approvals, 2022
  • Employment in Life & Physical Science Occupations by Business Type, U.S.: May 2022
  • Federal R&D & R&D Plant Funding for Basic Research, U.S.: Fiscal Years 2022-2024
  • U.S. Exports & Imports of Pharmaceutical Products: 2017-2022
  • Prescription Drug Expenditures, U.S.: Selected Years, 2015-2031
  • NSF Budget by Appropriation (Dollars in Millions), Fiscal Years 2022-2024
Chapter 3: Important Biotech, Pharmaceuticals & Genetics Industry Contacts
  • (Addresses, Phone Numbers and Internet Sites)
Chapter 4: THE BIOTECH 350:
  • Who They Are and How They Were Chosen
  • Index of Companies Within Industry Groups
  • Alphabetical Index
  • Index of U.S. Headquarters Location by State
  • Index of Non-U.S. Headquarters Location by Country
  • Individual Profiles on Each of THE BIOTECH 350
  • Additional Indexes
  • Index of Hot Spots for Advancement for Women/Minorities
  • Index by Subsidiaries, Brand Names and Selected Affiliations
  • A Short Biotech, Pharmaceuticals & Genetics Industry Glossary

Companies Mentioned

  • 23andMe Holding Co
  • 3SBio Inc
  • 4SC AG
  • Abbott Laboratories
  • AbbVie Inc
  • Abeona Therapeutics Inc
  • ACELYRIN Inc
  • Aceragen Inc
  • Achieve Life Sciences Inc
  • Acorda Therapeutics Inc
  • Adamis Pharmaceuticals Corporation
  • Adaptive Biotechnologies Corporation
  • Adcock Ingram Holdings Limited
  • Aeterna Zentaris Inc
  • Agenus Inc
  • Agilent Technologies Inc
  • AIM ImmunoTech Inc
  • Akebia Therapeutics Inc
  • Alcon Inc
  • Alimera Sciences Inc
  • ALK-Abello A/S
  • Alkermes Public Limited Company
  • Allergy Therapeutics PLC
  • Alnylam Pharmaceuticals Inc
  • Amarin Corporation plc
  • Amgen Inc
  • Amicus Therapeutics Inc
  • Amneal Pharmaceuticals Inc
  • Amyris Inc
  • Anika Therapeutics Inc
  • Anixa Biosciences Inc
  • Aptose Biosciences Inc
  • Arcadia Biosciences Inc
  • Armata Pharmaceuticals Inc
  • Aspira Womens Health Inc
  • Assertio Holdings Inc
  • Astellas Pharma Inc
  • AstraZeneca plc
  • Avadel Pharmaceuticals plc
  • Avid Bioservices Inc
  • BASF SE
  • Bausch & Lomb Incorporated
  • Bausch Health Companies Inc
  • Baxter International Inc
  • Bayer AG
  • BGI Genomics Co Ltd
  • BioCryst Pharmaceuticals Inc
  • Biogen Inc
  • BioMarin Pharmaceutical Inc
  • Bionano Genomics Inc
  • BioNTech SE
  • Bio-Rad Laboratories Inc
  • Bio-Techne Corporation
  • Biotest AG
  • Bioventus Inc
  • Bristol-Myers Squibb Company
  • Calyxt Inc
  • CareDx Inc
  • CASI Pharmaceuticals Inc
  • Cassava Sciences Inc
  • Cegedim SA
  • Celldex Therapeutics Inc
  • Cellectis SA
  • CEL-SCI Corporation
  • Cerus Corporation
  • Charles River Laboratories International Inc
  • Chembio Diagnostics Inc
  • Chemical Works of Gedeon Richter Plc
  • Chemomab Therapeutics Ltd
  • Chugai Pharmaceutical Co Ltd
  • CK Life Sciences Intl (Holdings) Inc
  • Cocrystal Pharma Inc
  • Collegium Pharmaceutical Inc
  • Compugen Ltd
  • Comvita Limited
  • Corteva Inc (bda Corteva Agriscience)
  • CSL Limited
  • CTI BioPharma Corp
  • Cumberland Pharmaceuticals Inc
  • Curis Inc
  • Cyanotech Corporation
  • Daiichi Sankyo Company Limited
  • Dechra Pharmaceuticals PLC
  • DiaSorin SpA
  • Divis Laboratories Limited
  • Dominari Holdings Inc
  • Dr Reddys Laboratories Limited
  • Durect Corporation
  • Editas Medicine Inc
  • Eisai Co Ltd
  • Elanco Animal Health Incorporated
  • Elementis PLC
  • Eli Lilly and Company
  • Emergent BioSolutions Inc
  • Endo International plc
  • Enzo Biochem Inc
  • Eurofins Scientific Group SA
  • Euro-Med Laboratories Phil Inc
  • Evotec SE
  • Exelixis Inc
  • Faes Farma SA
  • Fresh Tracks Therapeutics Inc
  • Fufeng Group Co Ltd
  • Galapagos NV
  • GE HealthCare Technologies Inc
  • Genomma Lab Internacional SAB de CV
  • Geron Corporation
  • Gilead Sciences Inc
  • Ginkgo Bioworks Holdings Inc
  • GoodRx Holdings Inc
  • GSK PLC
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
  • H Lundbeck A/S
  • Halozyme Therapeutics Inc
  • Harvard Bioscience Inc
  • Heska Corporation
  • Hikma Pharmaceuticals PLC
  • Horizon Therapeutics Public Limited Company
  • ICON plc
  • IDEXX Laboratories Inc
  • Illumina Inc
  • ImmuCell Corporation
  • ImmunoGen Inc
  • Incyte Corporation
  • Infinity Pharmaceuticals Inc
  • Inotiv Inc
  • Inovio Pharmaceuticals Inc
  • Insmed Incorporated
  • Integra LifeSciences Holdings Corporation
  • Integrated BioPharma Inc
  • IntelliPharmaCeutics International Inc
  • International Flavors & Fragrances Inc
  • Interpace Biosciences Inc
  • Ionis Pharmaceuticals Inc
  • Ipsen SA
  • IQVIA Holdings Inc
  • Ironwood Pharmaceuticals Inc
  • Jazz Pharmaceuticals Public Limited Company
  • Johnson & Johnson
  • Kangmei Pharmaceutical Co Ltd
  • LadRx Corp
  • Lannett Company Inc
  • Lexicon Pharmaceuticals Inc
  • Lifecore Biomedical Inc
  • LifeVantage Corporation
  • Ligand Pharmaceuticals Incorporated
  • Liminal BioSciences Inc
  • Lineage Cell Therapeutics Inc
  • Lonza Group AG
  • Mallinckrodt PLC
  • Mannatech Incorporated
  • Marizyme Inc
  • McKesson Europe AG
  • Merck & Co Inc
  • Merck KGaA
  • Mesoblast Limited
  • Microbot Medical Inc
  • Moderna Inc
  • Myriad Genetics Inc
  • Natural Alternatives International Inc
  • Navidea Biopharmaceuticals Inc
  • Nektar Therapeutics
  • NEOGEN Corporation
  • NeoGenomics Inc
  • Neurocrine Biosciences Inc
  • Nichi-Iko Pharmaceutical Co Ltd
  • Novartis AG
  • Novavax Inc
  • Novo Nordisk AS
  • Novozymes A/S
  • Oncotelic Therapeutics Inc
  • ONO Pharmaceutical Co Ltd
  • OPKO Health Inc
  • OraSure Technologies Inc
  • Organogenesis Holdings Inc
  • Organon & Co
  • Orion Oyj
  • Otsuka Holdings Co Ltd
  • Pacific Biosciences of California Inc
  • Pacira BioSciences Inc
  • Paion AG
  • Palatin Technologies Inc
  • Perrigo Company plc
  • Personalis Inc
  • Pfizer Inc
  • Polydex Pharmaceuticals Limited
  • Precigen Inc
  • Prestige Consumer Healthcare
  • ProPhase Labs Inc
  • PT Tempo Scan Pacific Tbk
  • QIAGEN NV
  • Quest Diagnostics Incorporated
  • Recordati Ord
  • Regeneron Pharmaceuticals Inc
  • Reliv International Inc
  • Repligen Corporation
  • RespireRx Pharmaceuticals Inc
  • Rigel Pharmaceuticals Inc
  • Roche Holding AG
  • Rohto Pharmaceutical Co Ltd
  • S&W Seed Company
  • Samsung BioLogics Co Ltd
  • Sangamo Therapeutics Inc
  • Sanofi SA
  • Sarepta Therapeutics Inc
  • SciClone Pharmaceuticals Holdings Limited
  • Seagen Inc
  • Seelos Therapeutics Inc
  • Shionogi & Co Ltd
  • SIGA Technologies Inc
  • Sihuan Pharmaceutical Holdings Group Ltd
  • Simcere Pharmaceutical Group Ltd
  • Sino Biopharmaceutical Limited
  • Sinovac Biotech Ltd
  • Soligenix Inc
  • Spectral Medical Inc
  • Spectrum Pharmaceuticals Inc
  • Standard BioTools Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • Sun Pharmaceutical Industries Limited
  • Swedish Orphan Biovitrum AB
  • Syneos Health Inc
  • Takeda Pharmaceutical Company Limited
  • Taro Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Limited
  • Thermo Fisher Scientific Inc
  • Titan Pharmaceuticals Inc
  • Toyobo Co Ltd
  • Trinity Biotech plc
  • Twist Bioscience Corporation
  • UCB SA
  • United Laboratories International Holdings Ltd
  • United Therapeutics Corporation
  • United-Guardian Inc
  • US Stem Cell Inc
  • Vaxart Inc
  • Vericel Corporation
  • Vertex Pharmaceuticals Incorporated
  • Vetoquinol SA
  • Viatris Inc
  • Virbac SA
  • Windtree Therapeutics Inc
  • XOMA Corporation
  • Xtant Medical Holdings Inc
  • Yield10 Bioscience Inc
  • Zimmer Biomet Holdings Inc
  • Zoetis Inc

Methodology

The data development evolved from research methods originally established by the founder of the company.

 

Through the years, a research methodology evolved based on strict guidelines used to build and maintain the content of six proprietary business and industry databases:

  • An industry trends database
  • An industry statistics database
  • Industry Analytics (deep financial data for hundreds of Industry codes)
  • A leading companies database
  • A business and industry glossary database
  • An industry associations and professional societies database
  • Analysts are trained to follow research formulas and methodology. They use company-approved sources in their work and post their findings daily to proprietary databases. All research results go through multi-step editing processes. And, all results are date-stamped.
Primary sources include:
  • Internal research, analysis, fact-checking and data gathering by the Research staff.
  • Over 3,500 industry associations, professional societies and government agencies worldwide with which the publisher maintains relationships and/or from which they obtain industry-specific/country-specific data.
  • Financial analysts, industry executives and industry experts with whom the publisher maintains communications.
  • Corporate disclosure documents and financial statements.
  • Industry conference proceedings.
  • Analysis of white papers, reports, periodicals and publications.
  • Multiple proprietaries, government, industry and financial databases developed by the publisher.

 

 

 

 

 

 

Loading
LOADING...